FDA Adverse Event Injury Summary report: N

RADIESSE INJECTABLE IMPLANT

MDR report key: 8437644 · Received March 20, 2019

Report

Report Number
2135225-2019-00019
Event Type
Injury
Date Received
March 20, 2019
Date of Event
February 28, 2019
Report Date
March 20, 2019
Manufacturer
MERZ NORTH AMERICA, INC.
Product Code
LMH
PMA / PMN Number
P050052
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

THIS CASE WAS ASSESSED AS REPORTABLE TO THE FDA AS THE EVENT, POSSIBLE VASCULAR OCCLUSION, WAS DEEMED TO MEET SERIOUS INJURY CRITERIA OF NECESSITATING MEDICAL OR SURGICAL INTERVENTION TO PRECLUDE PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO A BODY STRUCTURE. THE DEVICE HISTORY RECORD COULD NOT BE REVIEWED AS THE LOT NUMBER WAS NOT REPORTED.

Description of Event or Problem · 1

THIS SPONTANEOUS REPORT WAS RECEIVED FROM A NURSE AT A MEDICAL SPA AND CONCERNS A FEMALE PATIENT WHO WAS INJECTED WITH AN UNSPECIFIED AMOUNT OF RADIESSE TO THE NASOLABIAL FOLDS ON (B)(6) 2019. MEDICAL HISTORY AND CONCOMITANT MEDICATIONS NOT REPORTED. ON (B)(6) 2019, THE PATIENT REPORTED SEVERE PAIN AND BRUISING, POSSIBLE VASCULAR OCCLUSION. CAUSALITY, LOT, TREATMENT AND OUTCOME NOT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
231142 RADIESSE INJECTABLE IMPLANT IMPLANT, DERMAL, FOR AESTHETIC USE LMH MERZ NORTH AMERICA, INC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention